First-in-Human Trial Uses Laser Light to Attack Inoperable Pancreatic Tumors
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine